The Hindu

Access to generic Risdiplam sought under policy for rare diseases for people with Spinal Muscular Atrophy

The recent availability of India-manufactured generic Risdiplam offers a practical pathway, patients write in an appeal to the PM; access to treatment is time sensitive, with delays having the potential to cause irreversible deterioration in the life-limiting neuromuscular condition